Inclusion Criteria:  Genetically proven SMA patients treated with Nusinersen ''clinically definite ALS'' or ''clinically probable ALS'' or ''clinically probable ALS - laboratory supported'' according to the revised El Escorial diagnostic criteria or diagnosis of PMA or PLS  Exclusion Criteria:  No.